メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
関 守信
内科学(神経)
ウェブサイト
https://k-ris.keio.ac.jp/html/100003266_ja.html
h-index
1196
被引用数
17
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
1996 …
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(53)
類似のプロファイル
(6)
フィンガープリント
Morinobu Sekiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Neuroscience
Parkinson's Disease
100%
Alzheimer's Disease
44%
Single-Photon Emission Computed Tomography
32%
L-DOPA
29%
Positron Emission Tomography
25%
Amyloid
23%
Fluorine-18
22%
Dyskinesia
15%
Magnetic Resonance Imaging
15%
Limbic Encephalitis
12%
Dementia with Lewy Bodies
12%
Dopaminergic
10%
Tauopathy
10%
Encephalopathy
10%
Encephalitis
10%
4 Aminobutyric Acid B Receptor
10%
Meta-Analysis
10%
Rapid Eye Movement Sleep
10%
Nuclear Transport
10%
Immunoassay
10%
Electroconvulsive Therapy
10%
Behavior Disorder
10%
Receptor Antibody
10%
Amyotrophic Lateral Sclerosis
10%
Treatment of Pain
10%
Amyloid Protein
10%
Multiple System Atrophy
10%
Positron Emission Tomography
9%
Cerebellum
8%
Dopamine Transporter
7%
Non-Motor Symptoms
7%
Immunotherapy
7%
C-Terminus
7%
SARS Coronavirus
7%
Frontotemporal Dementia
6%
Gray Matter
6%
Functional Magnetic Resonance Imaging
6%
Putamen
6%
Iodine-123
6%
Glial Fibrillary Acidic Protein
6%
Temporal Lobe
5%
Mild Cognitive Impairment
5%
Cognitive Tests
5%
Magnetic Resonance Imaging of Brain
5%
Phenylalanine
5%
Longitudinal Study
5%
Keyphrases
Istradefylline
21%
Levodopa Therapy
13%
Intracranial Dissemination
10%
REM Sleep Behaviour Disorder Screening Questionnaire
10%
Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD)
10%
Camptocormia
10%
Pathological Brain
10%
Dopaminergic Depletion
10%
Depletion Pattern
10%
Intravenous Thrombolytic Therapy
10%
Acute Ischemic Stroke
10%
Developmental Venous Anomaly
10%
Translation Validation
10%
King's Parkinson's Disease Pain Scale
10%
Automated Immunoassay
10%
Polyradiculoneuropathy
10%
Metabolic Compartmentation
10%
Limbic Encephalitis
10%
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
10%
Tau Tracer
10%
PI-2620
10%
Neurologic Symptoms
10%
Normal Magnetic Resonance Imaging
10%
Autoimmune Encephalitis
10%
Autoimmune Neuropathy
10%
Phenylketonuria
10%
Ovarian Teratoma
10%
Laparoscopic Cystectomy
10%
Anti-N-methyl-D-aspartate Receptor Encephalitis
10%
Amyloid PET
10%
Source-based Morphometry
10%
Prediction Machines
10%
Amyloid Prediction
10%
Parkinson's Disease
10%
Progressive Supranuclear Palsy-parkinsonism
10%
Dentatorubrothalamic Tract
10%
P-tau181
10%
MRI Markers
10%
Multimodal MRI
10%
Atypical Parkinsonism
10%
Tau PET Imaging
10%
Autogenous Rib Graft
10%
Anti-NMDAR
10%
Dose Escalation
10%
Flexed Posture
10%
SLC9A6
10%
Adnexectomy
8%
Richardson's Syndrome
7%
Forward Flexion
7%
Hyperconnectivity
7%
Medicine and Dentistry
Parkinson's Disease
39%
Amyloid
32%
Pain Assessment
21%
Alzheimer's Disease
14%
Diagnosis
13%
Tau
13%
Patient Population
12%
Thorax Wall Reconstruction
10%
Camptocormia
10%
Spinal Cord Disease
10%
COVID-19
10%
Anti N Methyl D Aspartate Receptor Encephalitis
10%
Positron Emission Tomography
10%
Parkinsonism
10%
Single-Photon Emission Computed Tomography
10%
Polyradiculoneuropathy
10%
(3 Iodobenzyl)guanidine
10%
Bone Graft
10%
Immune Checkpoint Inhibitor
10%
Phenylketonuria
10%
Treatment of Pain
10%
Human T-Lymphotropic Virus 1
10%
Morphometrics
10%
Neoplasm
10%
Dextro Aspartic Acid
10%
Surgery
10%
Ovary Teratoma
10%
Dopamine Transporter
10%
Liver Transplantation
10%
Immunoassay
10%
Scintigraphy
10%
Disorders of Higher Cerebral Function
10%
Rib Graft
10%
Patient Care
10%
Desmoid Tumor
10%
Levodopa-Induced Dyskinesia
10%
Mild Cognitive Impairment
8%
Progressive Supranuclear Palsy
7%
N Methyl-D-Aspartate Receptor
7%
Thoracic Wall
7%
Chest
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Diffuse Lewy Body Disease
6%
Magnetic Resonance Imaging
6%
Gray Matter
6%
Hyperemesis Gravidarum
5%
